Asymmetrex, LLC

Asymmetrex, LLC Asymmetrex, LLC provides technology for rapid and accurate determination of the specific dosage of t PATENTED TECHNOLOGIES

2014 J. L. Sherley and J.-F. R. H.

Asymmetrex, LLC has a rich portfolio of stem cell technologies available for licensing. Depending on the technology and the planned use, both non-exclusive and exclusive licensing arrangements can be developed. Paré, “Method for Cloning Pluripotent Stem Cells,” U.S. Patent No. 8,759,098 B2.

2013 J. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 8,404,481

B2.

2011 J. Sherley and J. Merok, “Unique Properties of Stem Cells,” U.S. Patent No. 7,883,891.

2011 J. Sherley and M.-S. Noh, “Nucleic Acid Sequences Associated with Cell States,” U.S. Patent No. 7,867,712 B2.

2010 J. King, “Methods for Ex Vivo Propagation of Somatic Hair Follicle Stem Cells,” U.S. Patent No. 7,655,465 B2.

2010 J. Sherley and K. Panchalingam, “Methods for Ex Vivo Propagation of Adult Hepatic Stem Cells,” U.S. Patent No. 7,824,912 B2.

2010 J. Patent No. 7,645,610 B2. PENDING APPLICATIONS


2013 J. Sherley and Y. Huh, “Detecting and Counting Tissue-Specific Stem Cells and Uses Thereof,” US2013/0004965A1


2014 J. Sherley and J.-F., Pare,“ Methods for Producing Human Pancreatic Islet Precursor Cells and Uses Thereof.” International Application No. PCT/US2012/042644.

NAM Stem Cells?Register now to join Asymmetrex® Wed, May 6 to hear our pitch for partners to validate a new approach met...
04/30/2026

NAM Stem Cells?
Register now to join Asymmetrex® Wed, May 6 to hear our pitch for partners to validate a new approach methodology (NAM) for early detection of tissue stem cell-toxic drugs.
https://icont.ac/51h5Y

Register now to join Asymmetrex® Wed, May 6 to hear our pitch for partners to validate a new approach methodology (NAM) based on KSC counting.

Asymmetrex at COG-NE 2026, April 28, presenting on the importance of cell standards for recently accelerated 3Rs (replac...
04/23/2026

Asymmetrex at COG-NE 2026, April 28, presenting on the importance of cell standards for recently accelerated 3Rs (replacement, refinement, reduction) efforts to reduce the use of animals in testing and reserch.
https://icont.ac/51gPn

Asymmetrex at COG-NE 2026, April 28, discussing the importance of cell standards for accelerated 3Rs (replacement, refinement, reduction) efforts.

A new Drug Discovery World perspective highlights recent discoveries made using Asymmetrex®'s differential stem cell cou...
04/01/2026

A new Drug Discovery World perspective highlights recent discoveries made using Asymmetrex®'s differential stem cell counting technology. https://icont.ac/51fXJ

A new Drug Discovery World perspective highlights recent discoveries made using Asymmetrex®'s differential stem cell counting technology.

FDA recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard for regenerative medicin...
01/14/2026

FDA recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard for regenerative medicine. Learn how Asymmetrex® joined in informing this important new designation: https://icont.ac/51cx3

FDA recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard for regenerative medicine. Learn more about it.

FDA CBER recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard (VCS) for accelerat...
01/13/2026

FDA CBER recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard (VCS) for accelerating advances in regenerative medicine. Learn how Asymmetrex® joined in informing this important new designation: https://bitesizebio.com/86478/cell-proliferation-rate/
Repost to share.

12/23/2025
In this season of light and hope, an appreciation from Asymmetrex®
12/23/2025

In this season of light and hope, an appreciation from Asymmetrex®

Inside Asymmetrex®: We will be at from December 6-10. Attending? Stop by Booth #1036 and learn more about new advance...
12/04/2025

Inside Asymmetrex®: We will be at from December 6-10. Attending? Stop by Booth #1036 and learn more about new advances on the near horizon from Asymmetrex for improving critical cell culture analyses: https://icont.ac/51aZQ
Repost

Inside Asymmetrex®: We will be at from December 6-10. Attending? Stop by Booth #1036 and learn more about coming new advances.

Asymmetrex®’s Tissue Cell Proliferation Quiz #12. Test your cell analyses knowledge! Visit Asymmetrex®’s company Linke...
12/02/2025

Asymmetrex®’s Tissue Cell Proliferation Quiz #12. Test your cell analyses knowledge! Visit Asymmetrex®’s company LinkedIn page to participate: https://icont.ac/51aQi

Asymmetrex®’s Tissue Cell Proliferation Quiz #12. Test your cell analyses knowledge! Visit Asymmetrex®’s company LinkedIn page to participate.

Address

P. O. Box 301179
Boston, MA
02130

Telephone

+16179906819

Website

Alerts

Be the first to know and let us send you an email when Asymmetrex, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Asymmetrex, LLC:

Shortcuts

Share

Our Story

Asymmetrex, LLC has a rich portfolio of stem cell technologies available for licensing. Depending on the technology and the planned use, both non-exclusive and exclusive licensing arrangements can be developed. PATENTED TECHNOLOGIES 2014 J. L. Sherley and J.-F. Paré, “Method for Cloning Pluripotent Stem Cells,” U.S. Patent No. 8,759,098 B2. 2013 J. L. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 8,404,481 B2. 2011 J. L. Sherley and J. R. Merok, “Unique Properties of Stem Cells,” U.S. Patent No. 7,883,891. 2011 J. L. Sherley and M.-S. Noh, “Nucleic Acid Sequences Associated with Cell States,” U.S. Patent No. 7,867,712 B2. 2010 J. L. Sherley and J. King, “Methods for Ex Vivo Propagation of Somatic Hair Follicle Stem Cells,” U.S. Patent No. 7,655,465 B2. 2010 J. L. Sherley and K. Panchalingam, “Methods for Ex Vivo Propagation of Adult Hepatic Stem Cells,” U.S. Patent No. 7,824,912 B2. 2010 J. L. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 7,645,610 B2. PENDING APPLICATIONS 2013 J. L. Sherley and Y. H. Huh, “Detecting and Counting Tissue-Specific Stem Cells and Uses Thereof,” US2013/0004965A1 2014 J. L. Sherley and J.-F., Pare,“ Methods for Producing Human Pancreatic Islet Precursor Cells and Uses Thereof.” International Application No. PCT/US2012/042644.